ArticleMultiple sclerosis journal - experimental, translational and clinical

The effect of disease modifying therapies on CD62L expression in multiple sclerosis.

Margarete Maria Voortman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.